Skip Ribbon Commands
Skip to main content
Translate
Translate
menu iconMenu
search iconSearch

UC San Diego Moores Cancer Center New Member of National Comprehensive Cancer Network

 

March 20, 2013  |   

On March 19, the National Comprehensive Cancer Network® (NCCN®) announced the election of University of California, San Diego Moores Cancer Center as the first and only San Diego-based NCCN Member Institution dedicated to improving the quality, effectiveness, and efficiency of care provided to patients with cancer.

Moores Cancer Center 

UC San Diego Moores Cancer Center was elected as the first and only San Diego-based National Comprehensive Cancer Center Network Member Institution. 

“We are proud to join this prestigious alliance of the world’s leading cancer centers,” said Paul Viviano, CEO of UC San Diego Health System. “The physicians, scientists and clinicians of UC San Diego Moores Cancer Center and NCCN, share a vision of creating a healthier world, one life at a time, through new science, new medicine and new cures.”

As a NCCN Member Institution, UC San Diego Moores Cancer Center will be part of a national network that develops the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) used as the standard for clinical policy in oncology, incorporating expert medical judgment and recommendations of multidisciplinary panels from NCCN Member Institutions.

“The National Comprehensive Cancer Network and the UC San Diego Health System are bringing the most effective therapeutic and prevention strategies to cancer patients,” said Scott M. Lippman, MD, director of the Moores Cancer Center. “We look forward to working with fellow premier NCCN institutions to impact the outcomes of cancer care and to influence the direction of the cancer field.”

Joining 22 other institution members of NCCN, Moores Cancer Center was selected because of its role in transforming cancer care and providing exceptional care to cancer patients. Moores Cancer Center is the only National Cancer Institute (NCI)-designated Comprehensive Cancer Center in the San Diego region. Its multi-disciplinary team approach includes translating the basic scientific discoveries of its research faculty into new treatments for cancer patients in the clinic.

“We are extremely pleased that UC San Diego Moores Cancer Center has been elected to institutional membership in the NCCN,” said Robert Carlson, MD, CEO of the National Comprehensive Cancer Network. “Moores Cancer Center adds substantial strength and expertise to the excellence of cancer care, research, and education characteristic of the other world-class member institutions.”

About the National Comprehensive Cancer Network®
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 23 of the world’s leading cancer centers, is dedicated to improving the quality, effectiveness, and efficiency of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.

# # #

Media Contact: Yadira Galindo, 619-543-6163, ygalindo@ucsd.edu

Related Specialties

Cancer



Media Contact

Related News

4/20/2015
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and p ...
4/20/2015
A decrease in the amount of time spent eating and an increase in overnight fasting reduces glucose levels and may reduce the risk of breast cancer among women, report University of California, San Die ...
4/20/2015
The threat of falsified medications, also referred to as counterfeit, fraudulent, and substandard, can be quite real, yet the full scope and prevalence of the problem is poorly understood, say researc ...
4/17/2015
Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices us ...
4/16/2015
The increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation t ...
4/16/2015
An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardi ...
4/13/2015
About one quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to a new study by researchers at Universit ...
4/9/2015
A family of proteins called G proteins are a recognized component of the communication system the human body uses to sense hormones and other chemicals in the bloodstream and to send messages to cells ...